Sign In
Buy AYTU
$2.23
+0.0800 (+3.72%)
At Close: Jul 31, 2026
Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement
08:00am, Thursday, 26'th Oct 2023
U.S. Food & Drug Administration Approval of the Prior Approval Supplement (PAS) Enables Transfer of Cotempla Production to Contract Manufacturer Upon Completion of Manufacturing Transfer of Adzenys XR
Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023
04:15pm, Monday, 09'th Oct 2023
ENGLEWOOD, CO / ACCESSWIRE / October 9, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced that
Best Penny Stocks? 4 Hot Stocks With News This Week
11:55am, Thursday, 28'th Sep 2023
What do you consider the best penny stocks? Are they the ones exploding higher within a single session?
Aytu BioPharma, Inc. (AYTU) Q4 2023 Earnings Call Transcript
07:01pm, Wednesday, 27'th Sep 2023
Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q4 2023 Earnings Call Transcript September 27, 2023 4:30 PM ET Company Participants Robert Blum - IR Josh Disbrow - CEO Mark Oki - CFO Conference Call Participants
Q4 2023 net revenue of $30.7 million; Adjusted EBITDA of $7.7 million Record Q4 2023 total prescriptions increased 32% compared to Q4 2022 Rx Segment net revenue of $23.3 million and Adjusted EBITDA o
Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023
08:25pm, Thursday, 21'st Sep 2023
ENGLEWOOD, CO / ACCESSWIRE / September 21, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report financ
Aytu BioPharma to Present at LD Micro Main Event XVI Conference
08:00am, Wednesday, 13'th Sep 2023
ENGLEWOOD, CO / ACCESSWIRE / September 13, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced th
Aytu BioPharma, Inc. (AYTU) Q3 2023 Earnings Call Transcript
09:57pm, Thursday, 11'th May 2023
Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q3 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Roger Weiss - Lytham Partners Josh Disbrow - Chief Executive Officer Mark Oki - Chief
Aytu BioPharma to Report Third Quarter Fiscal 2023 Financial Results on May 11, 2023
04:30pm, Thursday, 04'th May 2023
ENGLEWOOD, CO / ACCESSWIRE / May 4, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused prescri
Aytu BioPharma, Inc. (AYTU) Q2 2023 Earnings Call Transcript
09:35pm, Tuesday, 21'st Feb 2023
Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q2 2023 Earnings Conference Call February 21, 2023 4:30 PM ET Company Participants Roger Weiss - Lytham Partners Josh Disbrow - Chief Executive Officer Mark Oki - C
Aytu BioPharma to Report Second Quarter Fiscal 2023 Financial Results on February 21, 2023
03:00pm, Tuesday, 21'st Feb 2023
ENGLEWOOD, CO / ACCESSWIRE / February 21, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (Nasdaq:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused p
Aytu BioPharma to Report Second Quarter Fiscal 2023 Financial Results on February 14, 2023
08:00am, Tuesday, 07'th Feb 2023
ENGLEWOOD, CO / ACCESSWIRE / February 7, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused pr
Aytu BioPharma to Present at Lytham Partners Investor Select Conference on January 31
08:00am, Tuesday, 24'th Jan 2023
ENGLEWOOD, CO / ACCESSWIRE / January 24, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a commercial stage pharmaceutical and consumer health company providing pediatric-focused pr
4 Short Squeeze Penny Stocks To Watch In January 2023; Time To Buy?
07:21pm, Friday, 13'th Jan 2023
Short squeeze penny stocks to watch this month. The post 4 Short Squeeze Penny Stocks To Watch In January 2023; Time To Buy?
Aytu BioPharma, Inc. (AYTU) Q1 2023 Earnings Call Transcript
06:58pm, Monday, 14'th Nov 2022
Aytu BioPharma, Inc. (NASDAQ:AYTU ) Q1 2023 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Roger Weiss - Lytham Partners Josh Disbrow - CEO Mark Oki - CFO Conference Call P
